These decorated MBs preferentially targeted subcutaneous U14 cervical tumors upon US irradiation via direct binding of the anti-PD-L1 mAb to PD-L1 expressed on the surface of the cancer cells, which likely facilitated collateral uptake of miR-34a. The gene discussed is CD274; the disease is cancer.